Join
Live feed
·
INSIDERFilingvia Quantisnow
Xenon Pharmaceuticals Inc. logo

Director Gover Justin D. converted options into 2,645 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XENE· Xenon Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XENE (Xenon Pharmaceuticals Inc.) and more on Quantisnow.

Director Gover Justin D. converted options into 2,645 shares (SEC Form 4) | Quantisnow